Follow the 안트로젠 share price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares are quoted on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 안트로젠 has logged 28 public disclosures. The latest transaction was reported on 10 July 2026 (Purchase). Among the most active insiders: 이성구. Every trade is free.
28
Insider Decl.
n/a
Thresholds
n/a
11 ops.
Buy Volume
n/a
2 ops.
Sell Volume
5Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
안트로젠 es una empresa farmacéutica y de atención médica que cotiza en el mercado XKRX. Se especializa en el desarrollo de tratamientos biológicos y terapias innovadoras.